COMMUNIQUÉS West-GlobeNewswire

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
01/10/2025
Maetzold recognized among 586 applicants to The CEO Magazine’s 2025 Executive of the Year Awards — United States program FRIENDSWOOD, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a [...]
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01/10/2025
SARASOTA, FL, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]
NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
01/10/2025
Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the esophagus 85% (11/13) disease control rate (DCR) 69% (9/13) objective response rate (ORR); [...]
NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
01/10/2025
Le traitement a été bien toléré et la faisabilité de l’injection a été confirmée chez les 13 patients atteints d’adénocarcinome de l’œsophage localement avancé. Le taux de contrôle de la maladie (DCR, disease control [...]
Vital Nutrients Expands Clinical Line With New Formula for Women’s Hair Health
01/10/2025
MIDDLETOWN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- With female hair loss on the rise, Vital Nutrients is introducing Hair Growth Complex for Women , a clinically formulated supplement targeting the biological drivers [...]
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy
01/10/2025
Innovative 'Mosaic' Active Immunotherapy to Target Alzheimer's Disease Buffalo, NY , Oct. 01, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (POP BIO) , has been awarded a $2.46M USD grant by the National Institutes [...]
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
01/10/2025
WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
01/10/2025
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Artelo Biosciences Announces Closing of $2.0 Million Public Offering
01/10/2025
SOLANA BEACH, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
01/10/2025
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
01/10/2025
Initial clinical data for BDC-4182 Phase 1 dose escalation study now expected in 3Q 2026 Company is implementing a 50% workforce reduction to extend cash runway into 2027 REDWOOD CITY, Calif., Oct. 01, 2025 (GLOBE [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly [...]
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
01/10/2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 [...]
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2025
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare [...]
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
01/10/2025
Mechelen, Belgium ; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of [...]
Boyce Thompson Institute Launches the Jane Silverthorne Postdoctoral Fellowship Program
01/10/2025
Now accepting applications to support high-risk, high-reward research at the frontiers of plant science A message from Silvia Restrepo, President, Boyce Thompson Institute Ithaca, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- [...]
Comfort Keepers Ireland Unveils Study Forecasting Doubling of Homecare Demand by 2057
01/10/2025
Ireland’s Ageing Population Will Double Homecare Needs - Data Highlights Planning Required Dublin, Leinster , Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comfort Keepers Ireland today unveiled a new study highlighting the country [...]
EssilorLuxottica completes acquisition of Optegra
01/10/2025
EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition of Optegra from MidEuropa. Under the Optegra, Lexum and [...]

Pages